Determinants significance diltiazem plasma concentrations acute myocardial infarction Multicenter Diltiazem Postinfarction Trial Research Group total plasma diltiazem concentrations patients multicenter secondary intervention study diltiazem acute myocardial infarction determinants significance diltiazem concentrations patient population drug concentrations variety clinical variables case history forms Multiple linear regression analysis time last drug dose drug dose patient height index lean body weight patient age important determinants plasma concentration equivalent dose plasma diltiazem concentrations patient double patient Total weight drug dose affect plasma concentrations Whereas drug concentrations patients left-sided heart failure renal dysfunction hepatic disease beta blockers Diltiazem concentrations significant determinant diastolic arterial pressure systolic pressure heart rate concentration overall incidence adverse experiences drug concentrations occurrence second- third-degree atrioventricular block coronary care unit need temporary pacemaker patients drug concentration ng/ml patients concentrations atrioventricular block pacemaker risk atrioventricular block high diltiazem concentrations face acute inferior infarction results diltiazem pharmacologic clinical effects large population concentration-related consideration patient size age ventricular function diltiazem dose effective drug therapy reduced likelihood adverse effects 